Equillium
Equillium is a California-based biotechnology firm that develops and commercializes immune-modifying therapeutics for the treatment of autoimmune and inflammatory disorders.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Equillium Information
Geographic Data
Address: 2223 Avenida De La Playa
City: La Jolla
State: CA
Zip: 92037
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$30M
Raised Total:$85M
Social
Metrics
1,819,189Website Global Rank
14,482Website Monthly Traffic
Twitter Followers
Description
Equillium is a California-based biotechnology firm that develops and commercializes immune-modifying therapeutics for the treatment of autoimmune and inflammatory disorders.
Contact Phone:
+18582401200
Contact Email:
Equillium went public on 10/12/2018 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/12/2018
IPO Valuation:
$234M
Ticker Symbol:
EQ
IPO Price:
$14/share
Amount Raised:
$65M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2021 | Post-IPO Equity | 1 | $30M |
Decheng Capital Decheng Capital Decheng Capital Decheng Capital |
10/2018 | IPO | $65M |
|
10/2019 | Post-IPO Debt | 2 | $20M |
Oxford Finance LLC Silicon Valley Bank Oxford Finance LLC Silicon Valley Bank |
8/2020 | Post-IPO Equity | $35M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 9/2022 | Metacrine | |
| 2/2022 | Bioniz Therapeutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
